Dry eye therapy by rebamipide nanoparticles

HIGHLIGHTS

• who: Noriaki Nagai et al. from the Faculty of Pharmacy, Kindai University, Kowakae, Higashi-Osaka, Osaka, Japan have published the paper: Dry Eye Therapy by Rebamipide NanopArticles, in the Journal: Pharmaceutics 2020, 12, x FOR PEER REVIEW of /2020/
• what: The authors designed a novel sustained-release drug delivery system (DDS) for dry eye therapy by rebamipide nanoparticles. The information about this novel DDS route and creation of a nano-formulation can be used to design further studies aimed at therapy for dry eye.
• how: Meibum shows a high binding affinity to hydrophobic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.